689 related articles for article (PubMed ID: 31826996)
1. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
Beauclair G; Naimo E; Dubich T; Rückert J; Koch S; Dhingra A; Wirth D; Schulz TF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826996
[TBL] [Abstract][Full Text] [Related]
2. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1.
Wang V; Davis DA; Deleage C; Brands C; Choi HS; Haque M; Yarchoan R
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801863
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's Sarcoma-Associated Herpesvirus ORF21 Enhances the Phosphorylation of MEK and the Infectivity of Progeny Virus.
Yamaguchi T; Watanabe T; Iwaisako Y; Fujimuro M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674756
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425
[TBL] [Abstract][Full Text] [Related]
5. ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.
Wood JJ; Boyne JR; Paulus C; Jackson BR; Nevels MM; Whitehouse A; Hughes DJ
J Virol; 2016 Oct; 90(20):9543-55. PubMed ID: 27512077
[TBL] [Abstract][Full Text] [Related]
6. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
J Virol; 2017 May; 91(10):. PubMed ID: 28275189
[TBL] [Abstract][Full Text] [Related]
7. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
8. The Expression and Nuclear Retention Element of Polyadenylated Nuclear RNA Is Not Required for Productive Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
Gutierrez IV; Dayton J; Harger S; Rossetto CC
J Virol; 2021 Jun; 95(13):e0009621. PubMed ID: 33853955
[TBL] [Abstract][Full Text] [Related]
9. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase.
Cheng F; He M; Jung JU; Lu C; Gao SJ
J Virol; 2016 Jul; 90(14):6515-6525. PubMed ID: 27147746
[TBL] [Abstract][Full Text] [Related]
11. Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation.
Chen J; Dai L; Goldstein A; Zhang H; Tang W; Forrest JC; Post SR; Chen X; Qin Z
PLoS Pathog; 2019 Dec; 15(12):e1008156. PubMed ID: 31790497
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Developing Treatments of Kaposi's Sarcoma Herpesvirus-Related Diseases.
Naimo E; Zischke J; Schulz TF
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578378
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Interferes with mTORC1 Regulation of Autophagy and Viral Protein Synthesis.
Pringle ES; Robinson CA; McCormick C
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375594
[TBL] [Abstract][Full Text] [Related]
14. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
Wakeman BS; Izumiya Y; Speck SH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
[TBL] [Abstract][Full Text] [Related]
15. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
16. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
17. The DNase Activity of Kaposi's Sarcoma-Associated Herpesvirus SOX Protein Serves an Important Role in Viral Genome Processing during Lytic Replication.
Uppal T; Meyer D; Agarwal A; Verma SC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728255
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Is Independent of Anaphase-Promoting Complex Activity.
Elbasani E; Gramolelli S; Günther T; Gabaev I; Grundhoff A; Ojala PM
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295923
[TBL] [Abstract][Full Text] [Related]
19. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a Coregulatory Interaction between Kaposi's Sarcoma-Associated Herpesvirus ORF45 and the Viral Protein Kinase ORF36.
Avey D; Tepper S; Pifer B; Bahga A; Williams H; Gillen J; Li W; Ogden S; Zhu F
J Virol; 2016 Jul; 90(13):5953-5964. PubMed ID: 27099309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
